Multidrug-Resistant Tuberculous Meningitis in KwaZulu-Natal, South Africa

Patel, V. B.; Padayatchi, N.; Bhigjee, A. I.; Allen, J.; Bhagwan, B.; Moodley, A. A.; Mthiyane, T.
March 2004
Clinical Infectious Diseases;3/15/2004, Vol. 38 Issue 6, p851
Academic Journal
Multidrug-resistant (MDR) pulmonary tuberculosis (TB) is well described in the literature. Reports of MDR TB meningitis (MDR-TBM), however, are limited to case reports and a single case series. During the period of 1999–2002, 350 patients with TBM were identified by cerebrospinal fluid culture for TB. Thirty patients (8.6%) had TB that was resistant to at least isoniazid and rifampicin. All 30 patients were included in this study. We reviewed hospital charts of the patients with MDR-TBM and describe our experience. Seventeen patients with MDR-TBM died, and, of those who were known to be alive, many experienced significant morbidity. Eighteen patients were HIV positive. Twenty-two patients had been treated for TB in the past, 3 patients had received no previous treatment for TB, and the history of TB treatment was unknown for 5 patients. The study highlights the prevalence of MDR-TBM and identifies new challenges in the management of affected patients.


Related Articles

  • Drug-susceptibility Patterns of Mycobacterium tuberculosis in Mpumalanga Province, South Africa: Possible Guiding Design of Retreatment Regimen. Green, E.; Obi, C. L.; Nchabeleng, M.; De Villiers, B. E.; Sein, P. P.; Letsoalo, T.; Hoosen, A. A.; Bessong, P. O.; Ndip, R. N. // Journal of Health, Population & Nutrition;Feb2010, Vol. 28 Issue 1, p7 

    Multidrug-resistant tuberculosis (MDR-TB) has been a cause of concern in both developed and developing countries. The prevalence of drug resistance in Mycobacterium tuberculosis (MTB) isolates (n=692) from Mpumalanga province was assessed. In total, 692 (64%) MTB strains from cases with...

  • Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains .from a high-incidence setting.  // BMC Microbiology;2012, Vol. 12 Issue 1, p90 

    The article discusses a study which aims to identify the first-line drug resistance in Mycobacterium tuberculosis (TB) strains from a high-incidence setting in Sierra Leone. It states that 97 strains were analyzed for mutations and 50 were found to be either mono- or poly-resistant to rifampin,...

  • Epidemic Levels of Drug Resistant Tuberculosis (MDR and XDR-TB) in a High HIV Prevalence Setting in Khayelitsha, South Africa. Cox, Helen S.; McDermid, Cheryl; Azevedo, Virginia; Muller, Odelia; Coetzee, David; Simpson, John; Barnard, Marinus; Coetzee, Gerrit; van Cutsem, Gilles; Goemaere, Eric // PLoS ONE;2010, Vol. 5 Issue 11, p1 

    Background: Although multidrug-resistant tuberculosis (MDR-TB) is emerging as a significant threat to tuberculosis control in high HIV prevalence countries such as South Africa, limited data is available on the burden of drug resistant tuberculosis and any association with HIV in such settings....

  • Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Sharma, Surendra K.; George, Ninoo; Kadhiravan, Tamilarasu; Saha, Pradip K.; Mishra, Hemant K.; Hanif, Mahmud // Indian Journal of Medical Research;Oct2009, Vol. 130 Issue 4, p392 

    Background &; objective: Extensively drug-resistant tuberculosis (XDR-TB) is a difficult-to-treat form of multidrug-resistant tuberculosis (MDR-TB). High rates of XDR-TB have been reported from India. We sought to ascertain the prevalence of XDR-TB among patients with MDR-TB treated at a...

  • Multidrug-resistant TB in HIV-negative patients.  // American Family Physician;2/15/1996, Vol. 53 Issue 3, p964 

    Presents the study `Multidrug-Resistant Tuberculosis in Patients Without HIV Infection,' by E.E. Telzak, et al., published in the 1995 issue of `New England Journal of Medicine.' Treatment response to isoniazid of patients with drug-resistant tuberculosis; Second-line medications for...

  • The Evolution of Drug Resistance in Mycobacterium tuberculosis: From a Mono-Rifampin-Resistant Cluster into Increasingly Multidrug-Resistant Variants in an HIV-Seropositive Population. Bifani, Pablo; Mathema, Barun; Kurepina, Natalia; Shashkina, Elena; Bertout, Julie; Blanchis, Anne Sophie; Moghazeh, Soraya; Driscoll, Jeffrey; Gicquel, Brigitte; Frothingham, Richard; Kreiswirth, Barry N. // Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p90 

    We describe the genotypic and phenotypic characteristics of a mono-rifampin-resistant (RIFR) Mycobacterium tuberculosis strain cluster (designated AU-RIFR) and the acquisition of additional drug resistance. Drug susceptibility, sequences of regions that determine drug resistance, and basic...

  • Performance of the GenoType MTBDR Plus assay in routine settings: a multicenter study. Mironova, S.; Pimkina, E.; Kontsevaya, I.; Nikolayevskyy, V.; Balabanova, Y.; Skenders, G.; Kummik, T.; Drobniewski, F. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2012, Vol. 31 Issue 7, p1381 

    Former Soviet Union countries including the Baltic States (Latvia, Lithuania, and Estonia) are hot spots for an emerging epidemic of drug resistant tuberculosis (TB). As a part of the development of a co-ordinated network of centers for diagnostic trials across Eastern Europe we conducted a...

  • New Drug-Resistance Test Gives Hope to TB Fight.  // Clinical Infectious Diseases;9/1/2008, Vol. 47 Issue 5, piii 

    The article reports on the new drug-resistance test, unveiled by the World Health Organization (WHO), that will allow doctors in poor countries to find out within hours whether patients have drug-resistant tuberculosis (TB). According to the director of the WHO's Stop TB department Mario...

  • Tuberculous Meningitis Developing After Six Months of Treatment of Pulmonary Tuberculosis. D'Souza, Bernard J.; Lansky, Lester L.; Cho, Cheng T. // Clinical Pediatrics;Aug1975, Vol. 14 Issue 8, p729 

    The article presents a case of developing tuberculous meningitis while receiving treatment of pulmonary tuberculosis. Two possible mechanisms for treatment failure in the patient suggest themselves: the child was not given the isoniazid and PAS regularly, or the infecting strain of Mycobacterium...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics